Aspirin guided by coronary artery calcium scoring for primary cardiovascular prevention in persons with subclinical coronary atherosclerosis.

IF 2.5 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL American Journal of Medicine Pub Date : 2024-12-12 DOI:10.1016/j.amjmed.2024.11.032
J Siegel
{"title":"Aspirin guided by coronary artery calcium scoring for primary cardiovascular prevention in persons with subclinical coronary atherosclerosis.","authors":"J Siegel","doi":"10.1016/j.amjmed.2024.11.032","DOIUrl":null,"url":null,"abstract":"<p><p>Although endurance exercise is cardioprotective, episodes of strenuous physical exertion can trigger sudden cardiac death. While marathon training promotes overall heart health, running such races transiently increases cardiac arrest risk, mainly in middle-aged men with subclinical coronary atherosclerosis. Coronary artery calcium scanning has been advised for risk stratification to identify those who benefit from enhanced primary prevention. Based on a 40% reduction in first heart attacks in same-aged men in the final report on aspirin in the Physicians Health Study, low-dose aspirin has been recommended for such runners and elderly persons at increased risk for sudden cardiac death during recreational sports activity. This approach may also provide primary prevention for patients with conditions such as human immunodeficiency virus infection in which inflammation promotes progressive coronary atherosclerosis. This strategy is supported by a 31% reduction in major acute cardiac events with the addition of low-dose aspirin to the polypill in persons with moderate risk factors. Evidence-based in two randomized, controlled clinical trials, low-dose aspirin guided by coronary artery calcium scoring for primary prevention warrants timely consideration, given the sharply increasing burden of atherosclerosis forecast until 2050 by the American Heart Association.</p>","PeriodicalId":50807,"journal":{"name":"American Journal of Medicine","volume":" ","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.amjmed.2024.11.032","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Although endurance exercise is cardioprotective, episodes of strenuous physical exertion can trigger sudden cardiac death. While marathon training promotes overall heart health, running such races transiently increases cardiac arrest risk, mainly in middle-aged men with subclinical coronary atherosclerosis. Coronary artery calcium scanning has been advised for risk stratification to identify those who benefit from enhanced primary prevention. Based on a 40% reduction in first heart attacks in same-aged men in the final report on aspirin in the Physicians Health Study, low-dose aspirin has been recommended for such runners and elderly persons at increased risk for sudden cardiac death during recreational sports activity. This approach may also provide primary prevention for patients with conditions such as human immunodeficiency virus infection in which inflammation promotes progressive coronary atherosclerosis. This strategy is supported by a 31% reduction in major acute cardiac events with the addition of low-dose aspirin to the polypill in persons with moderate risk factors. Evidence-based in two randomized, controlled clinical trials, low-dose aspirin guided by coronary artery calcium scoring for primary prevention warrants timely consideration, given the sharply increasing burden of atherosclerosis forecast until 2050 by the American Heart Association.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
亚临床冠状动脉粥样硬化患者在冠状动脉钙化评分指导下服用阿司匹林进行心血管一级预防。
虽然耐力运动对心脏有保护作用,但剧烈运动也可能引发心脏性猝死。虽然马拉松训练能促进整体心脏健康,但参加这类比赛会短暂增加心脏骤停的风险,主要发生在亚临床冠状动脉粥样硬化的中年男性身上。冠状动脉钙扫描被建议用于风险分层,以确定哪些人可以从加强一级预防中获益。根据《医生健康研究》中关于阿司匹林的最终报告,同龄男性首次心脏病发作率降低了 40%,因此建议此类跑步者和在休闲体育活动中心脏性猝死风险较高的老年人服用低剂量阿司匹林。这种方法还可以为患有人类免疫缺陷病毒感染等疾病的患者提供一级预防,在这些疾病中,炎症会促进冠状动脉粥样硬化的发展。在具有中度风险因素的人群中,在多丸剂中添加低剂量阿司匹林后,重大急性心脏病事件减少了 31%,这为该策略提供了支持。两项随机对照临床试验证明,在冠状动脉钙化评分的指导下服用小剂量阿司匹林进行一级预防值得及时考虑,因为美国心脏协会预测到 2050 年动脉粥样硬化的负担将急剧加重。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
American Journal of Medicine
American Journal of Medicine 医学-医学:内科
CiteScore
6.30
自引率
3.40%
发文量
449
审稿时长
9 days
期刊介绍: The American Journal of Medicine - "The Green Journal" - publishes original clinical research of interest to physicians in internal medicine, both in academia and community-based practice. AJM is the official journal of the Alliance for Academic Internal Medicine, a prestigious group comprising internal medicine department chairs at more than 125 medical schools across the U.S. Each issue carries useful reviews as well as seminal articles of immediate interest to the practicing physician, including peer-reviewed, original scientific studies that have direct clinical significance and position papers on health care issues, medical education, and public policy.
期刊最新文献
Pseudo thrombotic microangiopathy caused by folic acid deficiency. Narrative Competency: The healing potential of storytelling. AEQUANIMITAS FOR OUR TIME. Aspirin guided by coronary artery calcium scoring for primary cardiovascular prevention in persons with subclinical coronary atherosclerosis. Implementing a Global Ethics Charter to Protect US Healthy Volunteers.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1